Immunogenicity and Safety of Pentaxim as 3 Doses Primary Vaccination Followed by a Booster Dose at 18 Months

Clinical trial NCT00453570 · COMPLETED

Trial details

NCT number: NCT00453570
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Tetanus Haemophilus Influenzae Type b Pertussis Poliomyelitis

Start date: 2007-03-01
Primary completion: 2008-12-01
Enrollment: 792

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.